Abstract
issue of this year’s Bulletin of Clinical Psychopharmacology, is deeply appreciated for emphasizing the possible drug-drug interactions (DDIs) and adverse effects (AE) that patients may experience while receiving antipsychotic polytherapy. This subject is of vital importance for patient safety, given that 5-20% of all hospitalizations for AE are reported to be caused by DDIs. Considering the frequency of serious adverse effects, this means that one in 200 hospitalized patients experienced a serious adverse effect as a consequence of DDIs
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
